HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic Mechanism of Macrophage Inflammatory Protein 1 α Neutralizing Antibody (CCL3) in Clostridium difficile Infection in Mice.

AbstractBACKGROUND:
Clostridium difficile infection (CDI) causes diarrhea and colitis. We aimed to find a common pathogenic pathway in CDI among humans and mice by comparing toxin-mediated effects in human and mouse colonic tissues.
METHOD:
Using multiplex enzyme-linked immunosorbent assay, we determined the cytokine secretion of toxin A- and B-treated human and mouse colonic explants.
RESULTS:
Toxin A and toxin B exposure to fresh human and mouse colonic explants caused different patterns of cytokine secretion. Toxin A induced macrophage inflammatory protein (MIP) 1α secretion in both human and mouse explants. Toxin A reduced the expression of chloride anion exchanger SLC26A3 expression in mouse colonic explants and human colonic epithelial cells. Patients with CDI had increased colonic MIP-1 α expression and reduced colonic SLC26A3 (solute carrier family 26, member 3) compared with controls. Anti-MIP-1 α neutralizing antibody prevented death, ameliorated colonic injury, reduced colonic interleukin 1β (IL-1β) messenger RNA expression, and restored colonic SLC26a3 expression in C. difficile-infected mice. The anti-MIP-1 α neutralizing antibody prevented CDI recurrence. SLC26a3 inhibition augmented colonic IL-1 β messenger RNA expression and abolished the protective effect of anti-MIP-1 α neutralizing antibody in mice with CDI.
CONCLUSION:
MIP-1 α is a common toxin A-dependent chemokine in human and mouse colon. MIP-1 α mediates detrimental effects by reducing SLC26a3 and enhancing IL-1 β expression in the colon.
AuthorsJiani Wang, Christina Ortiz, Lindsey Fontenot, Riya Mukhopadhyay, Ying Xie, Xinhua Chen, Hanping Feng, Charalabos Pothoulakis, Hon Wai Koon
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 221 Issue 10 Pg. 1623-1635 (04 27 2020) ISSN: 1537-6613 [Electronic] United States
PMID31793629 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].
Chemical References
  • Antibodies, Neutralizing
  • Bacterial Toxins
  • Ccl3 protein, mouse
  • Chemokine CCL3
  • Chloride-Bicarbonate Antiporters
  • Enterotoxins
  • Interleukin-1beta
  • Macrophage Inflammatory Proteins
  • RNA, Messenger
  • SLC26A3 protein, human
  • Sulfate Transporters
  • tcdA protein, Clostridium difficile
Topics
  • Animals
  • Antibodies, Neutralizing (immunology, therapeutic use)
  • Bacterial Toxins (toxicity)
  • Chemokine CCL3 (immunology)
  • Chloride-Bicarbonate Antiporters (genetics, metabolism)
  • Clostridioides difficile
  • Clostridium Infections (therapy)
  • Colon (drug effects, metabolism, microbiology)
  • Down-Regulation
  • Enterotoxins (toxicity)
  • Gene Expression Regulation (drug effects)
  • Humans
  • Interleukin-1beta (genetics, metabolism)
  • Macrophage Inflammatory Proteins (immunology)
  • Mice
  • RNA, Messenger (genetics, metabolism)
  • Sulfate Transporters (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: